Updated daily
View our work on COVID-19 vaccinations
Statistics and Research

Coronavirus (COVID-19) Vaccinations

Our international COVID-19 vaccination dataset is updated each morning (London time), with data up to the previous day.
Reuse our work freelyCite this research

Our vaccination dataset uses the most recent official numbers from governments and health ministries worldwide. The population estimates we use to calculate per-capita metrics are all based on the last revision of the United Nations World Population Prospects. A full list of our country-specific sources is available at the bottom of this page, and we also answer frequently-asked questions there.

In our Data Explorer you can see all of our data on COVID-19 vaccinations (doses administered, people with at least 1 dose, and people fully vaccinated).

Open the Data Explorer in a new tab.

Select a group of countries at once: all European countries, 30 largest countries; EU; Americas; OECD.


The Our World in Data COVID vaccination data

To bring this pandemic to an end, a large share of the world needs to be immune to the virus. The safest way to achieve this is with a vaccine. Vaccines are a technology that humanity has often relied on in the past to bring down the death toll of infectious diseases.

Within less than 12 months after the beginning of the COVID-19 pandemic, several research teams rose to the challenge and developed vaccines that protect from SARS-CoV-2, the virus that causes COVID-19.

Now the challenge is to make these vaccines available to people around the world. It will be key that people in all countries — not just in rich countries — receive the required protection. To track this effort we at Our World in Data are building the international COVID-19 vaccination dataset that we make available on this page. It is updated each morning, with the most recent official numbers up to the previous day.

  • Open access: as with all of our data, we are making this dataset openly available, so that everyone can check and use the data that we bring together. You find the vaccination data in our daily-updated repository on GitHub.
Our work belongs to everyone
Cite our vaccination data
Mathieu, E., Ritchie, H., Ortiz-Ospina, E. et al. A global database of COVID-19 vaccinations. Nat Hum Behav (2021)

Country-by-country data on COVID-19 vaccinations

This page has a number of charts on vaccination. In the box below you can select any country you are interested in — or several, if you want to compare countries.

All charts on this page will then show data for the countries that you selected.

None selected

What share of the population has been partly or fully vaccinated against COVID-19?

The following charts show the breakdown of vaccinations by those that have been partly or fully vaccinated. A person is considered partly vaccinated if they have received only one dose of a 2-dose vaccine protocol. A person is considered fully vaccinated if they have received a single-dose vaccine or both doses of a two-dose vaccine.

This data is only available for countries which report the breakdown of doses administered by first and second doses.

How many COVID-19 vaccine doses are administered daily?

Daily number of COVID-19 vaccinations administered per 100 people

The following chart shows the daily number of COVID-19 vaccination doses administered per 100 people (check the latest global vaccination rate). This is shown as the rolling seven-day average. Note that this is counted as a single dose, and may not equal the total number of people vaccinated, depending on the specific dose regime (e.g. people receive multiple doses).

Daily number of COVID-19 vaccinations administered

How many COVID-19 vaccination doses have been administered?

The following map and chart show the number of COVID-19 vaccination doses administered per 100 people within a given population. Note that this is counted as a single dose, and may not equal the total number of people vaccinated, depending on the specific dose regime as several available COVID vaccines require multiple doses.

Total number of COVID-19 vaccinations administered

The following chart shows the total number of COVID-19 vaccination doses administered. Note that this is counted as a single dose, and may not equal the total number of people vaccinated, depending on the specific dose regime (e.g. people receive multiple doses).

What share of the population has received at least one dose of the COVID-19 vaccine?

The following chart shows the share of the total population that has received at least one dose of the COVID-19 vaccine (check the latest global share). This may not equal the share that are fully vaccinated if the vaccine requires two doses. If a person receives the first dose of a 2-dose vaccine, this metric goes up by 1. If they receive the second dose, the metric stays the same.

Total number of people who have received at least one dose of the COVID-19 vaccine

The following chart shows the total number of people that have received at least one dose of the COVID-19 vaccine. This may not equal the number that are fully vaccinated if the vaccine requires two doses. If a person receives the first dose of a 2-dose vaccine, this metric goes up by 1. If they receive the second dose, the metric stays the same.

What share of the population has been fully vaccinated against COVID-19?

The following chart shows the share of the total population that has been fully vaccinated against COVID-19. This represents the share that have received all doses prescribed by the vaccination protocol. If a person receives the first dose of a 2-dose vaccine, this metric stays the same. If they receive the second dose, the metric goes up by 1.

This data is only available for countries which report the breakdown of doses administered by first and second doses.

Total number of people who have been fully vaccinated against COVID-19

The following chart shows the total number of people that have been fully vaccinated against COVID-19. This represents the number that have received all doses prescribed by the vaccination protocol. If a person receives the first dose of a 2-dose vaccine, this metric stays the same. If they receive the second dose, the metric goes up by 1.

This data is only available for countries which report the breakdown of doses administered by first and second doses.

Vaccinations by age

The following charts provide data on the share of people that have been vaccinated against COVID-19 by age group. This is provided as three metrics: the share that have received at least one dose; the share that have been fully vaccinated; and the share that are only partly vaccinated.

Some of this data is only available for countries which report the breakdown of doses administered by first and second doses by age.

Share that have received at least one dose by age

The following chart shows the share of the population in each age group that have received at least one dose of the COVID-19 vaccine. This metric includes those that are either partly or fully vaccinated.

Fully vaccinated by age

The following chart shows the share of the population in each age group that are fully vaccinated against COVID-19. This represents the share that have received all doses prescribed by the vaccination protocol.

Partly vaccinated by age

The following chart shows the share of the population in each age group that are only partly vaccinated against COVID-19. For a two-dose vaccine schedule, this would be people that have received only one dose.

Those who are fully vaccinated are not included. This means this metric will decrease as people receive their second dose.

Which vaccines have been administered in each country?

The following chart shows the cumulative number of doses administered, broken down by vaccine manufacturer.

This is only available for a select number of countries which report the necessary data.

Vaccination policies

This interactive chart maps government policies on COVID-19 vaccination. Note that this only tracks policies on the availability of vaccinations. It does not track the number of people who have been vaccinated.

Countries are grouped into six categories:

  • No availability
  • Availability for ONE of following: key workers/ clinically vulnerable groups / elderly groups
  • Availability for TWO of following: key workers/ clinically vulnerable groups / elderly groups
  • Availability for ALL of following: key workers/ clinically vulnerable groups / elderly groups
  • Availability for all three plus partial additional availability (select broad groups/ages)
  • Universal availability

Vaccination policy data is sourced from the Oxford Coronavirus Government Response Tracker

This data on vaccination policies is sourced from the Oxford Coronavirus Government Response Tracker (OxCGRT).

This resource is published by researchers at the Blavatnik School of Government at the University of Oxford: Thomas Hale, Anna Petherik, Beatriz Kira, Noam Angrist, Toby Phillips and Samuel Webster.

The tracker presents data collected from public sources by a team of over one hundred Oxford University students and staff from every part of the world.

The data presented here is taken directly from the OxCGRT project; Our World in Data do not track policy responses ourselves, and do not make additions to the tracker dataset.

These charts are regularly updated based on the latest version of the response tracker.

OxCGRT is an ongoing collation project of live data. If you see any inaccuracies in the underlying data, or for specific feedback on the analysis or another aspect of the project please contact OxCGRT team. See the tracker’s notes and guidance on data quality.

Attitudes to COVID-19 vaccinations

The Imperial College London YouGov Covid-19 Behaviour Tracker Data Hub gathers global insights on people’s behaviors in response to COVID-19. This survey covers public behaviors and attitudes ranging from mask-wearing to self-isolation, social distancing, symptoms and testing.

The following two charts show monthly data from this survey on the willingness of people to get vaccinated against COVID-19. Survey respondents were presented with the following statement: “If a COVID-19 vaccine were made available to me this week, I would definitely get it.” Respondents were asked to react to this statement on a 1 to 5 scale, ranging from “Strongly agree” (1) to “Strongly disagree” (5).

Based on this scale, we consider respondents to be willing to get a COVID-19 vaccine if they selected 1 or 2, unwilling to get a COVID-19 vaccine if they selected 4 or 5, and uncertain if they are willing to get a COVID-19 vaccine if they selected 3.

Both charts below show the share of a country’s population that has received at least one dose of a COVID-19 vaccine in comparison to the share of the population that is unvaccinated, where the share of the unvaccinated population is separated into those who would be willing vs. unwilling vs. uncertain if they would get a COVID-19 vaccine if it was made available to them this week.1

The first chart shows this data for a single country over time, while the second chart shows the same data for multiple countries at a single point in time.

Vaccine development: vaccines approved for use and in clinical trials

The speed at which the first COVID-19 vaccines were developed was extraordinary. We have previously looked into the history of vaccine development. The measles vaccine was found relatively rapidly: it took only 10 years from the discovery of the pathogen to the development of the first vaccine. But for typhoid it took more than a century, and for some diseases for which we’ve known the pathogens for more than a century (like malaria) we still haven’t found an effective vaccine.

The development of a vaccine against COVID-19 has been much faster than the development of any other vaccine. Within less than a year several successful vaccines have already been announced and were approved for use in some countries. 

The hope is that even more manufacturers develop vaccines for COVID-19. This will be important because eventually a very large share of the world population needs to receive a COVID-19 vaccine.

We are on the way to several vaccines against COVID-19 – vaccine trackers monitor the progress:

Several institutions maintain websites on which they list COVID-19 candidate vaccines that are currently being developed:

Source information country by country

You can download the full dataset alongside the detailed sources on GitHub.

Vaccination against COVID-19 has now started in 214 locations.

LocationSourceLast observation dateVaccines
AfghanistanWorld Health OrganizationJul. 18, 2021Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing
AlbaniaMinistry of HealthJul. 22, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik V
AlgeriaMinistry of HealthFeb. 19, 2021Sputnik V
AndorraGovernment of AndorraJul. 19, 2021Oxford/AstraZeneca, Pfizer/BioNTech
AngolaWorld Health OrganizationJul. 19, 2021Oxford/AstraZeneca
AnguillaWorld Health OrganizationJul. 23, 2021Oxford/AstraZeneca
Antigua and BarbudaMinistry of HealthJul. 21, 2021Oxford/AstraZeneca
ArgentinaMinistry of HealthJul. 24, 2021Oxford/AstraZeneca, Sinopharm/Beijing, Sputnik V
ArmeniaMinistry of HealthJul. 18, 2021Oxford/AstraZeneca, Sinovac, Sputnik V
ArubaGovernment of ArubaJul. 23, 2021Pfizer/BioNTech
AustraliaGovernment of Australia via covidlive.com.auJul. 24, 2021Oxford/AstraZeneca, Pfizer/BioNTech
AustriaMinistry of HealthJul. 23, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
AzerbaijanGovernment of AzerbaijanJul. 24, 2021Oxford/AstraZeneca, Sinovac, Sputnik V
BahamasPan American Health OrganizationJul. 17, 2021Oxford/AstraZeneca
BahrainMinistry of HealthJul. 24, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
BangladeshDirectorate General of Health ServicesJul. 24, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing
BarbadosMinistry of HealthJul. 21, 2021Oxford/AstraZeneca
BelarusWorld Health OrganizationJun. 13, 2021Sinopharm/Beijing, Sputnik V
BelgiumSciensanoJul. 22, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
BelizeMinistry of HealthJul. 22, 2021Oxford/AstraZeneca, Sinopharm/Beijing
BeninMinistry of HealthJul. 24, 2021Oxford/AstraZeneca, Sinovac
BermudaPan American Health OrganizationJul. 23, 2021Oxford/AstraZeneca, Pfizer/BioNTech
BhutanWorld Health OrganizationJul. 12, 2021Oxford/AstraZeneca, Pfizer/BioNTech
BoliviaMinistry of HealthJul. 12, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
Bonaire Sint Eustatius and SabaWorld Health OrganizationApr. 9, 2021Moderna, Pfizer/BioNTech
Bosnia and HerzegovinaPublic Health InstituteJul. 5, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik V
BotswanaMinistry of Health and WellnessJul. 16, 2021Oxford/AstraZeneca
BrazilMinistry of HealthJul. 24, 2021Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac
British Virgin IslandsWorld Health OrganizationJul. 23, 2021Oxford/AstraZeneca
BruneiMinistry of HealthJul. 23, 2021Oxford/AstraZeneca, Sinopharm/Beijing
BulgariaMinistry of HealthJul. 24, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
Burkina FasoWorld Health OrganizationJul. 24, 2021Oxford/AstraZeneca
CambodiaMinistry of HealthJul. 23, 2021Oxford/AstraZeneca, Sinopharm/Beijing, Sinovac
CameroonWorld Health OrganizationJul. 24, 2021Oxford/AstraZeneca, Sinopharm/Beijing
CanadaOfficial data from provinces via covid19tracker.caJul. 24, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
Cape VerdeWorld Health OrganizationJul. 24, 2021Oxford/AstraZeneca, Pfizer/BioNTech
Cayman IslandsCayman Islands GovernmentJul. 23, 2021Oxford/AstraZeneca, Pfizer/BioNTech
Central African RepublicAfrica Centres for Disease Control and PreventionJul. 24, 2021Covaxin, Oxford/AstraZeneca
ChadAfrica Centres for Disease Control and PreventionJul. 21, 2021Sinopharm/Beijing
ChileMinisterio de Ciencia, Tecnología, Conocimiento e InnovaciónJul. 20, 2021CanSino, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac
ChinaNational Health CommissionJul. 24, 2021CanSino, Sinopharm/Beijing, Sinopharm/Wuhan, Sinovac
ColombiaMinistry of HealthJul. 23, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac
ComorosWorld Health OrganizationJul. 24, 2021Covaxin, Oxford/AstraZeneca, Sinopharm/Beijing
CongoAfrica Centres for Disease Control and PreventionJul. 15, 2021Moderna, Oxford/AstraZeneca, Sinopharm/Beijing, Sputnik V
Cook IslandsSPC Public Health DivisionJul. 20, 2021Oxford/AstraZeneca
Costa RicaCosta Rican Social Security FundJul. 19, 2021Oxford/AstraZeneca, Pfizer/BioNTech
Cote d’IvoireMinistry of Health and Public HygieneJul. 21, 2021Oxford/AstraZeneca
CroatiaMinistry of HealthJul. 23, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
CubaMinistry of HealthJul. 22, 2021Abdala, Soberana02
CuracaoGovernment of CuracaoJul. 24, 2021Moderna, Pfizer/BioNTech
CyprusMinistry of HealthJul. 22, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
CzechiaMinistry of HealthJul. 24, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
Democratic Republic of CongoWorld Health OrganizationJul. 24, 2021Oxford/AstraZeneca
DenmarkStatens Serum InstituteJul. 23, 2021Johnson&Johnson, Moderna, Pfizer/BioNTech
DjiboutiWorld Health OrganizationJun. 23, 2021Oxford/AstraZeneca, Sinopharm/Beijing, Sinovac, Sputnik V
DominicaPan American Health OrganizationJul. 23, 2021Oxford/AstraZeneca, Sinopharm/Beijing
Dominican RepublicMinistry of Public HealthJul. 23, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac
EcuadorGovernment of Ecuador via EcuacovidJul. 21, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac
EgyptWorld Health OrganizationJul. 12, 2021Oxford/AstraZeneca, Sinopharm/Beijing, Sinovac, Sputnik V
El SalvadorMinistry of HealthJul. 23, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac
EnglandGovernment of the United KingdomJul. 23, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
Equatorial GuineaMinistry of HealthJul. 21, 2021Sinopharm/Beijing
EstoniaNational Health BoardJul. 23, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
EswatiniGovernment of EswatiniJul. 21, 2021Oxford/AstraZeneca
EthiopiaMinistry of HealthJul. 22, 2021Oxford/AstraZeneca
Faeroe IslandsGovernment of the Faeroe IslandsJul. 22, 2021Moderna, Pfizer/BioNTech
Falkland IslandsGovernment of the Falkland IslandsApr. 14, 2021Oxford/AstraZeneca
FijiSPC Public Health DivisionJul. 20, 2021Oxford/AstraZeneca
FinlandFinnish Institute for Health and WelfareJul. 24, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
FrancePublic Health FranceJul. 22, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
French PolynesiaSPC Public Health DivisionJul. 20, 2021Johnson&Johnson, Pfizer/BioNTech
GabonAfrica Centres for Disease Control and PreventionJul. 24, 2021Sinopharm/Beijing
GambiaAfrica Centres for Disease Control and PreventionJul. 15, 2021Oxford/AstraZeneca, Sinopharm/Beijing
GeorgiaNational Center for Disease Control and Public HealthJul. 22, 2021Oxford/AstraZeneca
GermanyRobert Koch InstitutJul. 23, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
GhanaWorld Health OrganizationJul. 19, 2021Oxford/AstraZeneca, Sputnik V
GibraltarGovernment of GibraltarJul. 23, 2021Pfizer/BioNTech
GreeceMinistry of HealthJul. 24, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
GreenlandGovernment of GreenlandJul. 23, 2021Moderna
GrenadaWorld Health OrganizationJul. 23, 2021Oxford/AstraZeneca
GuatemalaMinistry of HealthJul. 23, 2021Moderna, Oxford/AstraZeneca
GuernseyGovernment of GuernseyJul. 23, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
GuineaNational Health Security AgencyJul. 18, 2021Sputnik V
Guinea-BissauWorld Health OrganizationJul. 19, 2021Oxford/AstraZeneca, Sinopharm/Beijing
GuyanaMinistry of HealthJul. 23, 2021Oxford/AstraZeneca, Sputnik V
HaitiPan American Health OrganizationJul. 22, 2021Oxford/AstraZeneca
HondurasWorld Health OrganizationJul. 23, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sputnik V
Hong KongGovernment of Hong KongJul. 24, 2021Pfizer/BioNTech, Sinovac
HungaryGovernment of HungaryJul. 22, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
IcelandDirectorate of HealthJul. 23, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
IndiaGovernment of IndiaJul. 24, 2021Covaxin, Oxford/AstraZeneca, Sputnik V
IndonesiaMinistry of HealthJul. 24, 2021Moderna, Oxford/AstraZeneca, Sinopharm/Beijing, Sinovac
IranWorld Health OrganizationJul. 19, 2021Covaxin, Oxford/AstraZeneca, Sinopharm/Beijing, Sputnik V
IraqWorld Health OrganizationJul. 5, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
IrelandHeath Service ExecutiveJul. 23, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
Isle of ManIsle of Man GovernmentJul. 21, 2021Oxford/AstraZeneca, Pfizer/BioNTech
Israel (see FAQ)Government of IsraelJul. 24, 2021Moderna, Pfizer/BioNTech
ItalyExtraordinary commissioner for the Covid-19 emergencyJul. 24, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
JamaicaPan American Health OrganizationJul. 23, 2021Oxford/AstraZeneca
JapanPrime Minister’s OfficeJul. 20, 2021Moderna, Pfizer/BioNTech
JerseyGovernment of JerseyJul. 18, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
JordanGovernment of JordanJul. 24, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
KazakhstanGovernment of KazakhstanJul. 24, 2021QazVac, Sinopharm/HayatVax, Sputnik V
KenyaMinistry of HealthJul. 23, 2021Oxford/AstraZeneca, Sputnik V
KosovoMinistry of HealthJul. 8, 2021Oxford/AstraZeneca
KuwaitMinistry of HealthJul. 3, 2021Pfizer/BioNTech
KyrgyzstanMinistry of HealthJun. 23, 2021Sinopharm/Beijing, Sputnik V
LaosWorld Health OrganizationJul. 17, 2021Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik V
LatviaNational Health ServiceJul. 23, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
LebanonGovernment of LebanonJul. 24, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
LesothoWorld Health OrganizationJul. 5, 2021Oxford/AstraZeneca
LiberiaWorld Health OrganizationJul. 12, 2021Oxford/AstraZeneca
LibyaWorld Health OrganizationJul. 18, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik V
LiechtensteinFederal Office of Public HealthJul. 22, 2021Moderna, Pfizer/BioNTech
LithuaniaMinistry of HealthJul. 24, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
LuxembourgGovernment of LuxembourgJul. 22, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
MacaoGovernment of MacaoJul. 24, 2021Pfizer/BioNTech, Sinopharm/Beijing
MadagascarWorld Health OrganizationJun. 28, 2021Oxford/AstraZeneca
MalawiMinistry of HealthJun. 28, 2021Oxford/AstraZeneca
MalaysiaGovernment of MalaysiaJul. 24, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac
MaldivesPresidency of the MaldivesJul. 21, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing
MaliWorld Health OrganizationJul. 12, 2021Oxford/AstraZeneca
MaltaCOVID-19 Malta Public Health Response TeamJul. 22, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
MauritaniaAfrica Centres for Disease Control and PreventionJul. 24, 2021Oxford/AstraZeneca, Sinopharm/Beijing
MauritiusWorld Health OrganizationJul. 24, 2021Covaxin, Oxford/AstraZeneca, Sinopharm/Beijing
MexicoSecretary of HealthJul. 23, 2021CanSino, Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik V
MoldovaMinistry of HealthJul. 24, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
MonacoNational CouncilJul. 22, 2021Pfizer/BioNTech
MongoliaMinistry of Health via ikon.mnJul. 23, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
MontenegroGovernment of MontenegroJul. 24, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
MontserratWorld Health OrganizationJul. 23, 2021Oxford/AstraZeneca
MoroccoMinistry of HealthJul. 24, 2021Oxford/AstraZeneca, Sinopharm/Beijing
MozambiqueWorld Health OrganizationJul. 24, 2021Oxford/AstraZeneca, Sinopharm/Beijing
MyanmarWorld Health OrganizationJul. 1, 2021Oxford/AstraZeneca, Sinopharm/Beijing
NamibiaMinistry of Health and Social ServicesJul. 16, 2021Oxford/AstraZeneca, Sinopharm/Beijing
NauruSPC Public Health DivisionJul. 20, 2021Oxford/AstraZeneca
NepalGovernment of NepalJul. 24, 2021Oxford/AstraZeneca, Sinopharm/Beijing
NetherlandsRIVM via European CDCJul. 24, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
New CaledoniaSPC Public Health DivisionJul. 20, 2021Pfizer/BioNTech
New ZealandMinistry of HealthJul. 20, 2021Pfizer/BioNTech
NicaraguaWorld Health OrganizationJul. 16, 2021Oxford/AstraZeneca, Sputnik V
NigerWorld Health OrganizationJul. 5, 2021Oxford/AstraZeneca, Sinopharm/Beijing
NigeriaWorld Health OrganizationJul. 12, 2021Oxford/AstraZeneca
NiueSPC Public Health DivisionJul. 6, 2021Oxford/AstraZeneca
North MacedoniaGovernment of North MacedoniaJul. 19, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik V
Northern CyprusMinistry of HealthJun. 27, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac
Northern IrelandGovernment of the United KingdomJul. 23, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
NorwayNorwegian Institute of Public HealthJul. 22, 2021Moderna, Pfizer/BioNTech
OmanWorld Health OrganizationJul. 14, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik V
PakistanNational Command and Operation CentreJul. 21, 2021CanSino, Oxford/AstraZeneca, Sinopharm/Beijing, Sinovac, Sputnik V
Palestine (see FAQ)Ministry of HealthJul. 17, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sputnik V
PanamaMinistry of HealthJul. 24, 2021Oxford/AstraZeneca, Pfizer/BioNTech
Papua New GuineaWorld Health OrganizationJul. 13, 2021Oxford/AstraZeneca, Sinopharm/Beijing
ParaguayGovernment of ParaguayJul. 18, 2021Covaxin, Oxford/AstraZeneca, Sinopharm/Beijing, Sinovac, Sputnik V
PeruMinistry of HealthJul. 19, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing
PhilippinesGovernment of the PhilippinesJul. 23, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik V
PitcairnSPC Public Health DivisionJun. 21, 2021Oxford/AstraZeneca
PolandMinistry of HealthJul. 23, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
PortugalDirectorate General for Health via Data Science for Social GoodJul. 24, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
QatarMinistry of Public HealthJul. 24, 2021Moderna, Pfizer/BioNTech
RomaniaGovernment of Romania via datelazi.roJul. 23, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
RussiaOfficial data from local governments via gogov.ruJul. 24, 2021EpiVacCorona, Sputnik V
RwandaWorld Health OrganizationJul. 23, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
Saint HelenaGovernment of Saint HelenaMay. 5, 2021Oxford/AstraZeneca
Saint Kitts and NevisGovernment of Saint Kitts and NevisJul. 23, 2021Oxford/AstraZeneca
Saint LuciaMinistry of HealthJul. 21, 2021Oxford/AstraZeneca
Saint Vincent and the GrenadinesMinistry of HealthJul. 20, 2021Oxford/AstraZeneca
SamoaSPC Public Health DivisionJul. 20, 2021Oxford/AstraZeneca
San MarinoSocial Security InstituteJul. 22, 2021Pfizer/BioNTech, Sputnik V
Sao Tome and PrincipeWorld Health OrganizationJul. 24, 2021Oxford/AstraZeneca
Saudi ArabiaSaudi Health CouncilJul. 24, 2021Oxford/AstraZeneca, Pfizer/BioNTech
ScotlandGovernment of the United KingdomJul. 23, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
SenegalWorld Health OrganizationJul. 24, 2021Oxford/AstraZeneca, Sinopharm/Beijing
SerbiaGovernment of SerbiaJul. 23, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
SeychellesExtended Programme for ImmunisationJul. 22, 2021Oxford/AstraZeneca, Sinopharm/Beijing
Sierra LeoneWorld Health OrganizationJul. 5, 2021Oxford/AstraZeneca, Sinopharm/Beijing
SingaporeMinistry of HealthJul. 23, 2021Moderna, Pfizer/BioNTech, Sinovac
Sint Maarten (Dutch part)World Health OrganizationJul. 23, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
SlovakiaMinistry of HealthJul. 23, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
SloveniaNational Institute of Public Health via covid-19.sledilnik.orgJul. 24, 2021Oxford/AstraZeneca, Pfizer/BioNTech
Solomon IslandsSPC Public Health DivisionJul. 20, 2021Oxford/AstraZeneca
SomaliaWorld Health OrganizationJul. 11, 2021Oxford/AstraZeneca, Sinopharm/Beijing, Sinovac
South AfricaMinistry of HealthJul. 23, 2021Johnson&Johnson, Pfizer/BioNTech
South KoreaKorea Centers for Disease Control and PreventionJul. 23, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
South SudanWorld Health OrganizationJul. 19, 2021Oxford/AstraZeneca
SpainMinistry of HealthJul. 22, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
Sri LankaMinistry of Health’s Epidemiology UnitJul. 24, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
SudanWorld Health OrganizationJul. 18, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac
SurinameGovernment of SurinameJul. 24, 2021Oxford/AstraZeneca
SwedenPublic Health Agency of SwedenJul. 23, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
SwitzerlandFederal Office of Public HealthJul. 22, 2021Moderna, Pfizer/BioNTech
SyriaWorld Health OrganizationJul. 9, 2021Oxford/AstraZeneca, Sinopharm/Beijing, Sputnik V
TaiwanTaiwan Centers for Disease ControlJul. 23, 2021Moderna, Oxford/AstraZeneca
TajikistanWorld Health OrganizationJul. 11, 2021Oxford/AstraZeneca, Sinovac
ThailandGovernment of ThailandJul. 23, 2021Oxford/AstraZeneca, Sinovac
TimorWorld Health OrganizationJul. 13, 2021Oxford/AstraZeneca, Sinovac
TogoWorld Health OrganizationJul. 19, 2021Oxford/AstraZeneca
TongaSPC Public Health DivisionJul. 20, 2021Oxford/AstraZeneca
Trinidad and TobagoMinistry of HealthJul. 24, 2021Oxford/AstraZeneca, Sinopharm/Beijing
TunisiaMinistry of HealthJul. 19, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik V
TurkeyCOVID-19 Vaccine Information PlatformJul. 24, 2021Pfizer/BioNTech, Sinovac
TurkmenistanWorld Health OrganizationApr. 4, 2021EpiVacCorona, Oxford/AstraZeneca, Sinopharm/Beijing, Sputnik V
Turks and Caicos IslandsWorld Health OrganizationJul. 23, 2021Pfizer/BioNTech
TuvaluSPC Public Health DivisionJun. 15, 2021Oxford/AstraZeneca
UgandaMinistry of HealthJul. 22, 2021Oxford/AstraZeneca
UkraineMinistry of HealthJul. 24, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac
United Arab EmiratesNational Emergency Crisis and Disaster Management AuthorityJul. 20, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinopharm/Wuhan, Sputnik V
United KingdomGovernment of the United KingdomJul. 23, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
United StatesCenters for Disease Control and PreventionJul. 24, 2021Johnson&Johnson, Moderna, Pfizer/BioNTech
UruguayMinistry of Health via vacuna.uyJul. 24, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac
UzbekistanGovernment of UzbekistanJul. 20, 2021Oxford/AstraZeneca, RBD-Dimer, Sputnik V
VanuatuSPC Public Health DivisionJul. 20, 2021Oxford/AstraZeneca
VenezuelaPan American Health OrganizationJul. 12, 2021Sinopharm/Beijing, Sputnik V
VietnamGovernment of VietnamJul. 24, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing
WalesGovernment of the United KingdomJul. 22, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
Wallis and FutunaSPC Public Health DivisionJul. 20, 2021Oxford/AstraZeneca
YemenWorld Health OrganizationJul. 12, 2021Oxford/AstraZeneca
ZambiaGovernment of ZambiaJul. 24, 2021Oxford/AstraZeneca, Sinopharm/Beijing
ZimbabweMinistry of HealthJul. 22, 2021Sinopharm/Beijing

Frequently-asked questions

Which population data are the per-capita metrics based on?

The population estimates we use come from the United Nations World Population Prospects. We use this data for its reliability, its consistent methods, and because it makes our work much easier. The exact values can be viewed in our GitHub repository.

The United Nations estimates may not always reflect the latest censuses or national figures—but there are several reasons why we use this data over country-by-country national population estimates.

  • The UNWPP dataset is the standard in research. The main reason is that it uses a reliable and standardized methodology for all countries. For example, if we used individual country data, some may include overseas workers, expats, undocumented immigrants, etc. but others wouldn’t.
  • Using data from the UN allows us to get accurate population estimates for all territories in the world very easily. Finding and maintaining estimates based on national censuses would be very time-consuming for our small team, without bringing much additional value to our work.
  • Other reasons include the availability of yearly data (national censuses are only conducted every few years), and avoiding double-counting in cases of border disputes.

For all these reasons, the UN data is the best solution to bring accurate per-capita metrics to our COVID data.

Can the value of per-capita metrics exceed 100%?

The population estimates we use to calculate per-capita metrics are all based on the last revision of the United Nations World Population Prospects. The United Nations estimates may not always reflect the latest censuses or national figures. Additionally, it’s important to bear in mind that in some territories, vaccination coverage may include non-residents (such as tourists and foreign workers). For these reasons, per-capita metrics may sometimes exceed 100%.

What is the definition of a fully-vaccinated person?

In our data, fully-vaccinated people are those who have received all doses prescribed by their vaccination regimen (e.g. 2 doses for Pfizer/BioNTech, Moderna, Oxford/AstraZeneca, etc. and 1 dose for Johnson & Johnson, CanSino, etc.).

Some countries also allow for alternative definitions, such as having been infected with SARS-CoV-2 in the past and having received 1 dose of a two-dose regimen. We currently ignore these alternative definitions to preserve the common definition of fully vaccinated, i.e. all doses required in the vaccine regimen. This allows for an optimal comparability between countries.

How can we best estimate how many people have been vaccinated globally?

Because some countries — notably China, as of June 2021 — do not report breakdowns between first and second doses administered, we cannot know the exact number of people with at least 1 dose and people fully vaccinated in the world. The figures displayed on our charts for “World” only include data from countries that do publish this more precise information. Therefore, as long as some countries are only reporting partial data, these figures will underestimate the real number of people vaccinated and fully vaccinated globally.

Based on the number of doses administered, it is however possible to calculate a lower and upper bound of how many people have been vaccinated in these countries. For example, if 500 million doses have been used in China, they must have been administered to at least 250 million people (with 2 doses each), and up to 500 million people (with only 1 dose each).

We recommend citing the figure on our charts as the “confirmed number of people with at least 1 dose”.

A good proxy for estimating the “complete number of people with at least 1 dose” is:

My country has started vaccinating its population. Why is it missing from the charts?

Other countries that are not shown in our data may have also started vaccination campaigns. We’ll add them to our maps and charts as soon as numbers are verifiable based on public official sources. If you’re aware of an official source reporting numbers, please let us know using the “Feedback” button at the bottom of your screen.

Are participants in vaccine clinical trials included in your data?

We do not include participants in the vaccine arm of clinical trials, as this data is not available for many of the hundreds of trials currently taking place.

How do you report vaccinations performed in Israel and Palestine?

In our dataset and charts on COVID-19 vaccinations, we report vaccinations performed in Israel and Palestine separately.

The vaccination data is needed to understand how the pandemic is evolving. For this it is key to bring together the vaccination data with data on COVID-19 cases and COVID-19 deaths. Global health institutions that report on the pandemic are reporting these metrics separately: 

  • The World Health Organization reports the measures for Israel separately from Palestine in its data.
  • Johns Hopkins University also reports Israel separately from Palestine in its data on cases & deaths of COVID-19, which has been used worldwide in the last year.

Reporting the data for Palestine and Israel separately also allows us to show their respective reported vaccination levels. It makes clear what the respective vaccination levels are, as reported by the Government of Israel and the Palestinian Ministry of Health.

Finally, our dataset on COVID-19 vaccinations is sourced from official data published by governments and ministries of health from countries around the world. This is also the case for Israel and Palestine. We show figures for Palestine and Israel separately, as they are reported separately by the Government of Israel and the Palestinian Ministry of Health

The Populations Division of the United Nations reports population figures for countries around the world, and we are relying on their latest data (from their 2019 revision) for countries around the world of. They report a population of 8,655,541 people for Israel and a population of 5,101,416 people for Palestine.

The resulting shares of people vaccinated in Israel and Palestine can be seen in our COVID-19 Data Explorer.


Sign up for regular updates from Our World in Data


→ If you want to keep up-to-date with on our work on COVID-19, and the many other topics we cover you can sign up to our newsletter.